Russell Investments Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.34M | Sell |
203,878
-7,126
| -3% | -$152K | 0.01% | 1303 |
|
2025
Q1 | $4.07M | Buy |
211,004
+141,664
| +204% | +$2.73M | 0.01% | 1275 |
|
2024
Q4 | $1.24M | Sell |
69,340
-20,801
| -23% | -$371K | ﹤0.01% | 1906 |
|
2024
Q3 | $1.97M | Buy |
90,141
+83,085
| +1,178% | +$1.82M | ﹤0.01% | 1693 |
|
2024
Q2 | $55K | Buy |
7,056
+960
| +16% | +$7.49K | ﹤0.01% | 2742 |
|
2024
Q1 | $25.2K | Buy |
6,096
+3,579
| +142% | +$14.8K | ﹤0.01% | 2746 |
|
2023
Q4 | $6.57K | Hold |
2,517
| – | – | ﹤0.01% | 2873 |
|
2023
Q3 | $4.71K | Buy |
+2,517
| New | +$4.71K | ﹤0.01% | 3154 |
|
2022
Q1 | – | Sell |
-216,991
| Closed | -$582K | – | 2915 |
|
2021
Q4 | $582K | Buy |
216,991
+129,578
| +148% | +$348K | ﹤0.01% | 2388 |
|
2021
Q3 | $437K | Buy |
+87,413
| New | +$437K | ﹤0.01% | 2522 |
|